Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |